surmount-1 tirzepatide non-diabetic weight loss once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial surmount-1 trial tirzepatide non-diabetic obesity
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
00377-2/asset/5849e908-c26a-472e-b460-1c99904b95c5/main.assets/gr2.jpg)



















